ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Hypertensive Disorders of Pregnancy: A Can’t Miss Diagnosis

Matthew DeLaney, MD, FACEP, FAAEM and Matthew Zeitler, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Preeclampsia is a can’t-miss cause of maternal morbidity that presents during pregnancy and up to 6 to 8 weeks postpartum. In the ED or urgent care, severe-range blood pressure alone can establish severe disease and should trigger immediate evaluation rather than waiting hours for confirmation.

Recognizing Peripartum Hypertension

  • Postpartum risk window: Hypertensive disorders of pregnancy do not end at delivery; patients remain at risk for 6 to 8 weeks postpartum, so every triage screen should ask about current or recent pregnancy.
  • Common and dangerous disease: Preeclampsia and related hypertensive disorders affect up to 10% of pregnancies and remain a leading cause of maternal morbidity and mortality, including after discharge.
  • Spectrum of diagnoses: The framework matters: chronic hypertension begins before 20 weeks, gestational hypertension starts after 20 weeks, and preeclampsia adds proteinuria or a severe feature.
  • Severe feature shorthand: It only takes one severe feature to make preeclampsia severe, and sustained severe-range blood pressure is enough on its own. That distinction is worth hearing in the chapter.

Diagnosis and Initial Evaluation

  • Accurate blood pressure technique: Before labeling severe hypertension, use the correct cuff and seated or semi-reclined positioning; bad technique can misclassify risk in a time-sensitive obstetric emergency.
  • Do not wait four hours: For severe-range pressures, do not wait for the classic 4-hour spacing used in milder hypertension; a 15-minute sustained recheck is the actionable bedside standard.
  • Protein testing limits: Urine dipstick protein is imperfect, with roughly 60% sensitivity, so it should not be used alone to rule out preeclampsia when symptoms or pressure are concerning.
  • Severe disease markers: Red flags include platelets below 100,000, creatinine above 1.1, liver enzymes more than twice normal, pulmonary edema, refractory headache, visual scotoma, and HELLP syndrome.
  • Essential lab bundle: Patients with severe-range blood pressure need a focused workup with CBC, liver enzymes, creatinine, and urinalysis or a urine protein-creatinine ratio, even without other symptoms. We walk through the early ED priorities in the episode.

Emergency Recognition of Eclampsia

  • Seizure equals eclampsia: New-onset generalized tonic-clonic seizure or unexplained coma in a pregnant or recently postpartum patient should be treated as eclampsia until proven otherwise.
  • Superimposed preeclampsia risk: Patients with chronic hypertension can develop superimposed preeclampsia and may deteriorate quickly, making a previously familiar blood pressure history falsely reassuring.
  • Symptom-based suspicion: Headache that does not respond to medication, visual symptoms, and dyspnea from pulmonary edema are major warning signs even before protein results return.
  • Triage system safeguards: A visible EMR pregnancy or postpartum flag helps prevent missed diagnosis when the chief complaint looks non-obstetric, especially in recently delivered patients.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

  1. Troiano NH, et al. Maternal Mortality and Morbidity in the United States: Classification, Causes, Preventability, and Critical Care Obstetric Implications. J Perinat Neonatal Nurs. 2018;32(3):222-231. PMID: 30036304
  2. Brousseau EC, et al. Emergency Department Visits for Postpartum Complications. J Womens Health (Larchmt). 2018;27(3):253-257. PMID: 28937843
  3. Luo FY, et al. Can we predict and prevent emergency department visits for postpartum hypertensive complications in patients with hypertensive disorders in pregnancy? J Matern Fetal Neonatal Med. 2020;33(13):2241-2245. PMID: 30415592
  4. Druzin JL. A California Toolkit to Transform Maternity Care. California Maternal Quality Care Collaborative [Internet]. 2013 [cited 2023Jun3]; Available from: https://www.cmqcc.org/resources-tool-kits/toolkits/preeclampsia-toolkit
  5. Pauli JM, et al. Pitfalls With the New American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Clin Obstet Gynecol. 2017;60(1):141-152.PMID: 27977436
  6. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 2019;133(2):409-412.PMID: 30681541
  7. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020;135(6):1492-1495.PMID: 32443077
  8. Banke-Thomas A, Rosser C, Brady R, E Shields L. Patient costs and outcomes before and after the institution of a pre-eclampsia quality improvement initiative in a southwestern tertiary facility. J Obstet Gynaecol. 2019;39(6):748-752.PMID: 31008661
  9. Banayan JM. Postpartum Preeclampsia Diagnosis Not to Be Missed. J Cardiothorac Vasc Anesth. 2023;37(6):1039-1041.PMID: 36964082
  10. Katsi V, et al. Postpartum Hypertension. Curr Hypertens Rep. 2020;22(8):58. Published 2020 Aug 6.PMID: 32761267

Faculty